Integrin-mediated traction force enhances paxillin molecular associations and adhesion dynamics that increase the invasiveness of tumor cells into a three-dimensional extracellular matrix.

Mol Biol Cell
Authors
Keywords
Abstract

Metastasis requires tumor cells to navigate through a stiff stroma and squeeze through confined microenvironments. Whether tumors exploit unique biophysical properties to metastasize remains unclear. Data show that invading mammary tumor cells, when cultured in a stiffened three-dimensional extracellular matrix that recapitulates the primary tumor stroma, adopt a basal-like phenotype. Metastatic tumor cells and basal-like tumor cells exert higher integrin-mediated traction forces at the bulk and molecular levels, consistent with a motor-clutch model in which motors and clutches are both increased. Basal-like nonmalignant mammary epithelial cells also display an altered integrin adhesion molecular organization at the nanoscale and recruit a suite of paxillin-associated proteins implicated in invasion and metastasis. Phosphorylation of paxillin by Src family kinases, which regulates adhesion turnover, is similarly enhanced in the metastatic and basal-like tumor cells, fostered by a stiff matrix, and critical for tumor cell invasion in our assays. Bioinformatics reveals an unappreciated relationship between Src kinases, paxillin, and survival of breast cancer patients. Thus adoption of the basal-like adhesion phenotype may favor the recruitment of molecules that facilitate tumor metastasis to integrin-based adhesions. Analysis of the physical properties of tumor cells and integrin adhesion composition in biopsies may be predictive of patient outcome.

Year of Publication
2017
Journal
Mol Biol Cell
Volume
28
Issue
11
Pages
1467-1488
Date Published
2017 Jun 01
ISSN
1939-4586
DOI
10.1091/mbc.E16-09-0654
PubMed ID
28381423
PubMed Central ID
PMC5449147
Links
Grant list
R01 CA192914 / CA / NCI NIH HHS / United States
U01 CA202241 / CA / NCI NIH HHS / United States
U54 CA210184 / CA / NCI NIH HHS / United States
R01 GM112998 / GM / NIGMS NIH HHS / United States
U54 CA210190 / CA / NCI NIH HHS / United States
R01 CA174929 / CA / NCI NIH HHS / United States
R01 CA172986 / CA / NCI NIH HHS / United States
R01 HL082792 / HL / NHLBI NIH HHS / United States